Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

LTRN Q1 2019 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena

LTRNLantern Pharma Inc.

$30M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$453,973

Net Income

-$453,973

EPS (Diluted)

$-0.07

Cash Flow

Operating Cash Flow

-$425,607

Free Cash Flow

-$425,607

Stock-Based Comp.

$15,531

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

-$201,798

Cash & Equivalents

-$445,163

← FY 2019 All Quarters Q2 2019 →